Estrella Immunopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Cap	49	59	43	38	41	58
Market Cap Growth	36.84%	36.40%	13.97%	-6.25%	-30.52%	0.91%
Enterprise Value	47.56	57.85	42.51	33.94	43.17	58.5
Last Close Price	1.15	1.56	1.20	1.05	10.84	10.00
PB Ratio	-	-5.71	302.14	8.92	-6.03	-
P/TBV Ratio	-8.36	-5.54	304.87	6.66	-2.28	-
Net Debt / Equity Ratio	0.37	0.13	-6.38	-0.97	0.37	-
Net Debt / EBITDA Ratio	0.14	0.11	-	0.57	0.22	-
Net Debt / FCF Ratio	-	0.78	0.12	0.26	1.86	-
Quick Ratio	0.22	0.10	0.31	23.05	0.28	-
Current Ratio	0.24	0.12	0.55	24.65	0.28	-
Return on Equity (ROE)	169.49%	255.59%	0.00%	592.27%	329.68%	0.00%
Return on Assets (ROA)	-387.79%	-413.55%	0.00%	-195.43%	-734.01%	0.00%
Return on Invested Capital (ROIC)	-625.19%	-687.40%	0.00%	-1516.91%	-3272.48%	0.00%
Return on Capital Employed (ROCE)	169.48%	255.57%	0.00%	595.20%	330.30%	0.00%
Buyback Yield / Dilution	-5.23%	-0.84%	-34.72%	-1809.14%	75.73%	-396.02%
Total Shareholder Return	-5.23%	-0.84%	-34.72%	-1809.14%	75.73%	-396.02%

SEC Filings: 10-K · 10-Q